Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiationDiane C. Ling, Umamaheswar Duvvuri, Peyman Kabolizadeh et al.|Oral Oncology|2016Cited by 107
Phase I trial of cetuximab, intensity modulated radiotherapy (IMRT), and ipilimumab in previously untreated, locally advanced head and neck squamous cell carcinoma (PULA HNSCC)Julie E. Bauman, Dwight E. Heron, Robert L. Ferris et al.|Annals of Oncology|2016Cited by 8